University of Maryland Greenebaum Comprehensive Cancer Center

02/11/2026

02/07/2026

You can register today at the following link:
https://research.umgccc.org/umgccc-event-calendar/spotlight-stomach-cancer-2026

01/13/2026

Registration is now open for the Spring 2026 Spotlight on Stomach Cancer, led by Dr. Jeremy Davis, Chief, Division of Surgical Oncology, Department of Surgery, University of Maryland School of Medicine, at the University of Maryland Greenebaum Comprehensive Cancer Center.

This event provides a welcoming space to learn, share experiences, and connect with others impacted by stomach cancer. Through expert presentations and discussions, participants will gain practical guidance and insights into stomach cancer risk, care, and emerging research.

Join us and other experts on May 15 in Baltimore, Maryland, to learn about options for stomach cancer treatment and meet others who share similar experiences.

Register below for in-person or virtual attendance.

https://research.umgccc.org/umgccc-event-calendar/spotlight-stomach-cancer-2026

01/12/2026

Vivian Walters went in for what she thought would be a routine hysterectomy with Dr. Harry Johnson at UMMC. During surgery, Dr. Johnson discovered an issue with her appendix, and a biopsy later confirmed a rare appendiceal tumor, a diagnosis found in fewer than six people per million.

Vivian was quickly connected with gastrointestinal cancer expert Dr. Benjamin Powers, surgical oncologist, and UMGCCC’s expert care team. After thorough testing, Vivian and Dr. Powers created a treatment plan for her low-grade appendiceal mucinous neoplasm (LAMN), which had spread to the lining of her abdomen.
Vivian later underwent an 11-hour CRS-HIPEC procedure to remove the disease, and she has since made steady progress in her recovery. Dr. Powers emphasizes that Vivian’s journey highlights the importance of early detection and coordinated, compassionate care.

Read more about Vivian’s journey: https://www.umms.org/umgccc/cancer-services/cancer-types/gastrointestinal/diagnostic-treatment/hyperthermic-intraperitoneal-chemotherapy/patient-story

01/12/2026

Vivian Walters went in for what she thought would be a routine hysterectomy with Dr. Harry Johnson at UMMC. During surgery, Dr. Johnson discovered an issue with her appendix, and a biopsy later confirmed a rare appendiceal tumor, a diagnosis found in fewer than six people per million.

Vivian was quickly connected with gastrointestinal cancer expert Dr. Benjamin Powers, surgical oncologist, and UMGCCC’s expert care team. After thorough testing, Vivian and Dr. Powers created a treatment plan for her low-grade appendiceal mucinous neoplasm (LAMN), which had spread to the lining of her abdomen.

Vivian later underwent an 11-hour CRS-HIPEC procedure to remove the disease, and she has since made steady progress in her recovery. Dr. Powers emphasizes that Vivian’s journey highlights the importance of early detection and coordinated, compassionate care.

Read more about Vivian’s journey: https://www.umms.org/umgccc/cancer-services/cancer-types/gastrointestinal/diagnostic-treatment/hyperthermic-intraperitoneal-chemotherapy/patient-story?fbclid=IwY2xjawPSQxNleHRuA2FlbQIxMABicmlkETFTckdJUkRVUVIyVTQ2bll2c3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHriaUGA5oAdWzycR0VoETdY70JYxQPblXq9QnCEitf7sLVZAocNK3mgzYlc6_aem_8cTqDVFWSUmrcCoVHd0UzQ

01/06/2026

"With this study, it is my personal belief that proton beam therapy is a new standard-of-care treatment for patients with oropharyngeal cancer."
Dr. Jason K. Molitoris, is a co-author of the study featured in this article from The Baltimore Sun on proton vs. photon beam therapy in patients with oropharyngeal cancer.

To read the full article, visit:

Proton beam radiation therapy performed 10% better at stopping cancer of the throat compared to traditional X-ray radiation, a new study shows, with 15% fewer side effects.

12/15/2025

We’re proud to have served as a clinical care site in a landmark study on oropharyngeal cancer recently published in The Lancet.
The collaborative Phase III clinical trial found that proton therapy offers significant benefits for patients with oropharyngeal cancer, including longer life span and fewer side effects. This is now the largest randomized study directly comparing proton and photon radiation for this disease. Dr. Jason Molitoris is co-author alongside physician scientists from over 17 intuitions nationwide including MD Anderson Cancer Center, Mayo Clinic and Massachusetts General Hospital.
These findings reinforce the power of proton therapy to improve outcomes and preserve long-term quality of life. It is our privilege to be Maryland’s resource for proton therapy, providing access to not only lifesaving, but quality of life saving treatment.

View the abstract and full paper at https://www.thelancet.com/.../PIIS0140-6736(25.../abstract

We’re proud to have served as a clinical care site in a landmark study on oropharyngeal cancer recently published in The Lancet.

The collaborative Phase III clinical trial found that proton therapy offers significant benefits for patients with oropharyngeal cancer, including longer life span and fewer side effects. This is now the largest randomized study directly comparing proton and photon radiation for this disease. Dr. Jason Molitoris is co-author alongside physician scientists from over 17 intuitions nationwide including MD Anderson Cancer Center, Mayo Clinic and Massachusetts General Hospital.

These findings reinforce the power of proton therapy to improve outcomes and preserve long-term quality of life. It is our privilege to be Maryland’s resource for proton therapy, providing access to not only lifesaving, but quality of life saving treatment.

View the abstract and full paper at https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01962-2/abstract

12/12/2025

Vivian Walters went in for what she thought would be a routine hysterectomy with Dr. Harry Johnson at UMMC. During surgery, Dr. Johnson discovered an issue with her appendix, and a biopsy later confirmed a rare appendiceal tumor, a diagnosis found in fewer than six people per million.

Vivian was quickly connected with gastrointestinal cancer expert Dr. Benjamin Powers, surgical oncologist, and UMGCCC’s expert care team. After thorough testing, Vivian and Dr. Powers created a treatment plan for her low-grade appendiceal mucinous neoplasm (LAMN), which had spread to the lining of her abdomen.
Vivian later underwent an 11-hour CRS-HIPEC procedure to remove the disease, and she has since made steady progress in her recovery. Dr. Powers emphasizes that Vivian’s journey highlights the importance of early detection and coordinated, compassionate care.

Read more about Vivian’s journey: https://www.umms.org/umgccc/cancer-services/cancer-types/gastrointestinal/diagnostic-treatment/hyperthermic-intraperitoneal-chemotherapy/patient-story

12/09/2025

Glioblastoma is the deadliest form of brain cancer. A new study is bringing hope that it could be survivable.
The publication in The Lancet Oncology, led by Dr. Graeme Woodworth, Professor and Chair of Neurosurgery at the University of Maryland School of Medicine and Neurosurgeon-In-Chief at UMMC, shows promising results.
The study is the first to find a potential survival benefit to adding focused ultrasound to standard chemotherapy.
The key advancement is getting treatment directly into the brain. The blood–brain barrier normally blocks toxins but it also blocks most therapies. Focused ultrasound temporarily opens this barrier, which allows chemotherapy to enter the brain and target the dangerous cancer cells that remain after standard treatment. The barrier then closes again.
The goal is to use focused ultrasound to treat tumors more effectively, monitor for signs of regrowth, and re-treat patients when needed. This form of treatment is currently only available in clinical trials and work still needs to be done to confirm these results in larger studies, but Dr. Woodworth says this is an exciting step forward.

Read the full story in The Baltimore Banner: https://www.thebanner.com/community/public-health/focused-ultrasound-study-glioblastoma-brain-cancer-LAGEPSTQ2RBPHJGX7VG7PFNXQM/

12/04/2025

Where Innovation Meets Compassion.
The Stoler Center for Advanced Medicine is more than steel and glass - it’s a place built on hope.

This new home for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) brings together world-class experts, compassionate caregivers, and the latest technology - all focused on one mission: helping every patient heal.

Hear more from University of Maryland Medical System, University of Maryland Medical Center, and University of Maryland Greenebaum Comprehensive Cancer Center leaders as they share what this milestone means for the future of cancer care.

Learn more about the Stoler Center for Advanced Medicine: www.umm.edu/StolerCenter

11/30/2025

Quitting smoking is the single best choice you can make for your health. But it’s also good for your wallet. Consider the amount of money you’ll save when you quit–including the decreased health and life insurance costs. Looking for ways to quit? Check out these resources: https://health.umms.org/2019/09/24/how-to-quit-smoking/

11/29/2025

Did you know? Smoking can lead to various health problems, including heart disease, stroke, COPD, and asthma. Are you looking for ways to quit? Read more here:

We know it is hard to quit smoking. But it is worth it. Get tips to help you quit and learn why it is important to get a lung screening.